Previous Page  2 / 17 Next Page
Information
Show Menu
Previous Page 2 / 17 Next Page
Page Background

Cancer Summit & Neuro Congress 2018

Cancer Therapy | Organ Specific Cancers | Cancer Management & Prevention

Title:

IL-17-MMP7-EMT axis as potential druggable target in the prevention and

treatment of prostate cancer

Zongbing You,

Tulane University School of Medicine, USA

Title:

FXYD3: A promising biomarker for cancer treatment

Chia-chi Liu,

University of Sydney, Australia

Title:

Prognostic association of plasma cell free DNA based androgen receptor

amplification and circulating tumor cells in pre-chemotherapy metastatic

castration resistant prostate cancer patients treated with abiraterone

acetate

Manish Kohli,

Mayo Clinic, USA

Title:

Dead-box RNA helicase DP103 enhances YAP sumoylation for YAP-TEAD

dependance and statin sensitivity in triple negative breast cancer

Alan Prem Kumar,

Cancer Science Institute of Singapore, Singapore

Title:

Therapeutic targeting of TFF3 inhibits oncogenesis in colorectal cancer

Rumei Chen,

National University of Singapore, Singapore

Session Chair

Zongbing You

Tulane University School

of Medicine, USA

J u n e 2 1 , 2 0 1 8

SESSIONS

D a y 1

Session Introduction